James Brugarolas, Director, Kidney Cancer Program; Sherry Wigley Crow Endowed Chair in Cancer Research; Professor, Internal Medicine/ Hematology-Oncology, Cancer Biology, Genetics, Development and Disease

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Consultant
    Topic: 
    Arrowhead Pharmaceuticals
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Consultant
    Topic: 
    Exelixis, Inc.
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Consultant
    Topic: 
    Eisai
    Date added: 
    12/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Consultant
    Topic: 
    Johnson & Johnson
    Date added: 
    12/02/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Consultant
    Topic: 
    Calithera
    Date added: 
    12/02/2021
Return to 156 Renal Cell Carcinoma Multimodality Conference: (080122)